TY - JOUR
T1 - Survival After Conservative Management Versus External Beam Radiation Therapy in Elderly Patients With Localized Prostate Cancer
AU - Dell'Oglio, Paolo
AU - Boehm, Katharina
AU - Trudeau, Vincent
AU - Tian, Zhe
AU - Larcher, Alessandro
AU - Leyh-Bannurah, Sami Ramzi
AU - Moschini, Marco
AU - Capitanio, Umberto
AU - Shariat, Shahrokh F.
AU - Briganti, Alberto
AU - Montorsi, Francesco
AU - Saad, Fred
AU - Karakiewicz, Pierre I.
PY - 2016/1/22
Y1 - 2016/1/22
N2 - Purpose: To compare survival in elderly men with clinically localized prostate cancer (PCa) according to treatment type, defined as radiation therapy (RT) with or without androgen deprivation therapy (ADT) versus conservative management (observation). Methods and Materials: In the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database, we identified 23,790 patients aged 80 years or more with clinically localized PCa treated with either RT or observation between 1991 and 2009. Competing risks analyses focused on cancer-specific mortality and other-cause mortality, after accounting for confounders. All analyses were repeated after stratification according to grade (well-differentiated vs moderately differentiated vs poorly differentiated disease), race, and United States region, in patients with no comorbidities and in patients with at least 1 comorbidity. Analyses were repeated within most contemporary patients, namely those treated between 2001 and 2009. Results: Radiation therapy was associated with more favorable cancer-specific mortality rates than observation in patients with moderately differentiated disease (hazard ratio [HR] 0.79; 95% confidence interval [CI] 0.66-0.94; . P=.009) and in patients with poorly differentiated disease (HR 0.58; 95% CI 0.49-0.69; . P
AB - Purpose: To compare survival in elderly men with clinically localized prostate cancer (PCa) according to treatment type, defined as radiation therapy (RT) with or without androgen deprivation therapy (ADT) versus conservative management (observation). Methods and Materials: In the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database, we identified 23,790 patients aged 80 years or more with clinically localized PCa treated with either RT or observation between 1991 and 2009. Competing risks analyses focused on cancer-specific mortality and other-cause mortality, after accounting for confounders. All analyses were repeated after stratification according to grade (well-differentiated vs moderately differentiated vs poorly differentiated disease), race, and United States region, in patients with no comorbidities and in patients with at least 1 comorbidity. Analyses were repeated within most contemporary patients, namely those treated between 2001 and 2009. Results: Radiation therapy was associated with more favorable cancer-specific mortality rates than observation in patients with moderately differentiated disease (hazard ratio [HR] 0.79; 95% confidence interval [CI] 0.66-0.94; . P=.009) and in patients with poorly differentiated disease (HR 0.58; 95% CI 0.49-0.69; . P
UR - http://www.scopus.com/inward/record.url?scp=84979738946&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84979738946&partnerID=8YFLogxK
U2 - 10.1016/j.ijrobp.2016.05.004
DO - 10.1016/j.ijrobp.2016.05.004
M3 - Article
AN - SCOPUS:84979738946
SN - 0360-3016
JO - International Journal of Radiation Oncology Biology Physics
JF - International Journal of Radiation Oncology Biology Physics
ER -